US3368555A - Respiration apparatus with fluid amplifier - Google Patents

Respiration apparatus with fluid amplifier Download PDF

Info

Publication number
US3368555A
US3368555A US51158865A US3368555A US 3368555 A US3368555 A US 3368555A US 51158865 A US51158865 A US 51158865A US 3368555 A US3368555 A US 3368555A
Authority
US
United States
Prior art keywords
control
main
inspiration
flow
conduit means
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Inventor
Noel F Beasley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Puritan Compressed Gas Corp
Original Assignee
Puritan Compressed Gas Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Puritan Compressed Gas Corp filed Critical Puritan Compressed Gas Corp
Priority to US51158865 priority Critical patent/US3368555A/en
Application granted granted Critical
Publication of US3368555A publication Critical patent/US3368555A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/10Fluid amplifiers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00Fluid handling
    • Y10T137/206Flow affected by fluid contact, energy field or coanda effect [e.g., pure fluid device or system]
    • Y10T137/212System comprising plural fluidic devices or stages
    • Y10T137/2125Plural power inputs [e.g., parallel inputs]
    • Y10T137/2147To cascaded plural devices

Description

United States Patent 3,368,555 RESPIRATION APPARATUS WITH FLUID AMPLIFIER Noel F. Beasley, Santa Monica, Calif., assignor to Puritan Compressed Gas Corporation, Kansas City, Mo., a corporation of Missouri Filed Dec. 2, 1965, Ser. No. 511,588 9 Claims. (Cl. 128145.8)
This application relates to respiration apparatus for use in administering intermittent positive pressure breathing therapy, and more particularly to improve apparatus of this type embodying fluid amplifiers.
Intermittent positive pressure breathing, commonly known as IPPB, is a type of assisted breathing for patients who are breathing spontaneously at a self-controlled rate and rhythm. Such therapy has wide-spread acceptance as an effective means for relieving and treating many respiratory disorders.
In IPPB therapy, the patient initiates the inspiratory phase of the breathing cycle by making a slight inspiratory effort as in normal breathing. Gas comprising air or air enriched with oxygen, or in some cases an admixture of such gas and vaporized or nebulized medication is then supplied to the lungs under a mild pressure to achieve ventilation. The inspiratory phase continues, preferably until full and even ventilation has occurred. As this condition is approached, the flow of gas to the patient drops off rapidly to a low level and eventually to a so-called terminal flow. This terminal flow is the flow taking place just at the end of the inspiration.
Following the inspiratory phase is an expiratory phase. This is a passive phase in which the pressure is rapidly reduced, preferably to ambient pressure, and the lungs are vented to the atmosphere. Expiration then occurs spontaneously, as in normal breathing, because of the elasticity of the lung-thorax system. Completion of expiration normally ends a given breathing cycle.
It is desired that apparatus for administering such IPPB therapy have certain operational characteristics. One such characteristic is that the patient-etfort required to initiate inspiration be no greater than that exerted in normal breathing. It is also desirable that the peak flow capacity of the apparatus be relatively high. This stems from the fact that the average patient has a high flow requirement near the start of inspiration. His requirement thereafter progressively decreases and, therefore, flow likewise decreases as pressure increases to the terminal flow which, as noted above, exists at the end of inspiration.
Another desirable operational characteristic is that the apparatus have a very low terminal flow. This enables full and even ventilation of the alveoli to be achieved. By way of explanation, the lungs comprise a network of small passages of varying resistance leading to the alveoii. With a low terminal flow, pressure is maintained on these passages for a sufiicient time to insure that the desired ventilation is achieved.
Besides these operational characteristics, there are many other important considerations to be borne in mind in the design and manufacture of respiration apparatus. In view of the nature of such apparatus, it is apparent that reliability is a highly important feature. Experience has shown that reliability is diflicult as well as costly to obtain with respiration apparatus embodying conventional valving mechanisms with numerous moving parts. Manufacture to close tolerances, closely controlled inspection and testing and the like, are all required in order to achieve the desired end with many types of apparatus heretofore available. Often costs are prohibitive and even assuming they are not, there is still the problem of potential abuse during use, resulting in malfunction. Thus, it
3,368,555 Patented Feb. 13, 1968 will be readily appreciated that it is highly desirable from a reliability standpoint to eliminate moving parts.
In view of the foregoing, it is a primary object of this invention to provide respiration apparatus which is highly reliable in operation.
A further, more specific object is to provide such respiration apparatus which has virtually no moving parts.
Another object of the invention is to provide respiration apparatus of the subject type further characterized in that a slight patient-effort is ample to initiate the inspiratory phase of the breathing cycle and in that it has a high peak flow capacity and a low terminal flow.
It is another object to provide respiration apparatus of the type described which is readily adapted to be thoroughly cleaned foliowing use.
A still further object is to provide respiration apparatus capable of accomplishing all of the foregoing objects, yet which is simple in construction and may be mass produced at an extremely low cost.
These and other objects, features and advantages of the invention will be better understood by referring to the following detailed description taken in conjunction with the accompanying drawings, in which:
FIGURE 1 is a semi-schematic view of the presently preferred embodiment of the invention, with the certain elements being shown in the positions occupied during the expiratory phase of the breathing cycle;
FIGURE 2 is a sectional view of suitable fluid amplifiers for use in the apparatus of FIGURE 1, with the amplifiers being shown schematically as connected to one another and with gas flow taking place as during the expi atory phase of the breathing cycle;
FIGURE 3 is a semi-schematic view, similar to FIG- URE l, of a modified version of the apparatus of the invention; and
FIGURE 4 is a sectional view, similar to FIGURE 2, of suitable fluid amplifiers for use in the apparatus of FIGURE 3.
Referring to the drawings, and in particular to FIGURE 1, the presently preferred apparatus of the invention, designated by the reference numeral 10, includes a main fluid amplifier 12 and a control fluid amplifier 14. These amplifiers 12 and 14 are, in turn, connected to one another 7 and to main conduit means 16 leading from a source 18 both a pump and a tank of compressed oxygen. As is conventional, the source 18 embodies suitable regulation apparatus for insuring that the gas supplied to the patient is at a mild pressure no greater than a preset maximum. Preferably, for flexibility of use, the regulation apparatus is adjustable to enable the maximum pressure to be preset within a safe range, e.g., 10 to 40 centimeters of water.
The delivery means 20 serves to establish communication between the respiration apparatus and the patients respiratory system. Such means may comprise any of T the many known types of devices adapted for this purpose,
including face masks and mouth pieces.
Preferably, the main amplifier 12 is a pure fluid amplifier, that is, it has no moving parts. It is formed in accordv ance with known procedures, having a plurality of shallow,
inner-connected channels and associated nozzles, as illustrated in FIGURE 2. These include an inlet channel 22 connected by an upstream section of the conduit means 16 to the source 18, and a main nozzle 24. A main stream of pressurized gas from the source issues from the main nozzle 24 into a receiving cavity 26 separated by a splitter 28, which is spaced away from the nozzle 24, into a patient channel 30 and an exhaust channel 32. As may be seen in FIGURES 1 and 2, the patient channel 30 is connected by a downstream section of the main conduit means 16 to the delivery means and the exhaust channel 32 is vented to atmosphere. Therefore, as is apparent, gas flowing through the patient channel is delivered to the patient, while gas flowing through the exhaust channel 32 is exhausted into the atmosphere.
The illustrative amplifier 12 is constructed so that without external influence, the main stream of gas issuing from nozzle 24 would divide substantially equally between the patient channel 30 and exhaust channel 32. In other words, the stream has no preferred position. For the purpose of directing the main stream initially toward one or the other of the channels 30 and 32 and directing or switching it therebetween, control means are provided. Such means here comprise inspiration and expiration control nozzles 34 and 36 arranged so that positive pres sure signals issuing from them direct the main stream toward the patient and exhaust channels 30 and 32, respectively.
It is also preferred, though not essential, that the amplifier 12 be bistable in nature and of the boundary layer, lock-on type. As is well known, this may be achieved by suitably configurating the side walls 26a and 26b of the receiving cavity 26. With such a wall configuration, once the stream is directed by pressure signals from the control nozzles 32 and 34 toward one or the other of the channels 30 and 32, the main stream locks to the adjacent wall in a self-reinforcing action, and the entire stream will then flow down that channel. When a pressure signal of sufficient amplitude to overcome the lock-on phenomenon issues from the control nozzles then adjacent the stream,
he stream is directed toward the other of the channels. It is to be noted that in the present case, as will be explained more fully below, positive pressure signals issue from the inspiration and expiration control nozzles 34 and 36 throughout the respective phases of a given cycle, thus serving independently of the lock-on effects to maintain the stream in a given one of the channels 30 and 32.
The amplifier 12 is operable so that even it back pressure in the outlet channel 30 substantially increases, as flow takes place through it, the established flow through that channel will continue. In practice, back pressure does in fact substantially increase in the patient channel 36 near the end of the inspiratory phase. For the desired full and even ventilation to be achieved, it is desired that flow through the patient channel continue, even when pressure in the conduit means 16 adjacent the delivery means 20 approaches the preset maximum pressure delivered by the source 13. Here flow continues notwithstanding the back pressure by virtue of the signal issuing continuously from nozzle 34 throughout inspiration and, also, by virtue of the main stream locking onto the wall 26a adjacent the patient channel 30. It is noted in passing that the channel 30 is never completely blocked. While the terminal flow preferably is low, as noted above, some flow takes place even at the very end of inspiration.
Pressurized gas is supplied to the nozzles 34 and 36 for directing the main stream toward the patient and exhaust channels 30 and 32, respectively, and maintaining it there by the control fluid amplifier 14. The latter amplifier is similar to the amplifier 12 in many respects, having an inlet channel 38 and an associated power nozzle 40. A control stream of gas issuing from the nozzle 40 enters a receiving cavity 42 with side walls 42a and 42b and separated by a splitter 43 into an inspiration outlet channel 44 and an expiration outlet channel 46. The channel 44, in turn, is coupled to the inspiration control nozzle 34 of the main amplifier 12 by a conduit 48, and the channel 46 is likewise coupled to the expiration control nozzle 36 by a conduit 50.
The control amplifier 14 is furnished with pressurized gas through a conduit 52 which, in the present case, is connected to the source 18. Such gas may be a relatively small stream and at relatively reduced pressure, since it need only have ample energy to overcome the lock-on phenomenon of the main amplifier 12 and direct the main stream of gas in the manner described above. The source 18 serves as a convenient and entirely satisfactory supply of gas for the control amplifier.
The control amplifier 14, like amplifier 12, preferably is of the boundary layer, lock-on type. However, it differs from amplifier 12 to the extent that it is monostable in nature, with its stable position being that in which the control stream flows through the expiration outlet channel 46. In addition, the amplifier '14 has a preferred position corresponding to channel 46, so that, without external influence, the control stream will still lock onto the side wall 42b of the cavity 42 adjacent the expiration channel 46. By way of further explanation, when the control stream initially issues from a nozzle 40 on startup, lock-on will immediately take place, so that flow is entirely through channel 46. Moreover, if flow is occurring through the inspiration channel 44 under external influence or bias and such influence or bias is removed, the control stream will immediately switch back to its preferred position in the channel 46.
In order to achieve such operation of the control amplifier 14, it will be appreciated that it is necessary to prevent the control stream from locking onto the wall 42a of the cavity 42 adjacent the inspiration channel 44. As is known in the fluid amplifier field, this can be accomplished in several ways. One Way is to space the side wall 42a away from the flow path by making it semi heartshaped, as in FIGURE 2.
For the purpose of directing or switching the control stream to the inspiration outlet channel 44 and maintaining it there throughout inspiration, control nozzle means are provided. In the illustrative embodiment, such means comprise first and second control nozzles 54 and 56. The first control nozzle 54 is arranged to issue initially, in a given breathing cycle, a negative pressure signal to direct the control stream to the inspiration outlet channel 44. At a later stage of the cycle, a positive pressure signal issues from the nozzle 54. The second control nozzle 56, on the other hand, is arranged to issue a positive pressure signal for maintaining the control stream in the inspiration outlet channel 44.
Pressure signals are supplied to the control nozzles 54 and 56 in accordance with the pressure then existing at the location of the sensing elements in the conduit means 16 downstream of the amplifier 12. In this connection, a venturi 58 in the conduit means 16 is connected by a passageway 60 opening at its throat 62 to the nozzle 54 by an auxiliary conduit 64. Flow through the venturi 58 produces a velocity increase and pressure drop at the throat 62, which is transmitted as a pressure signal, either positive or negative with respect to atmospheric pressure, through the conduit 64 to the nozzle 54. The second control nozzle 56 is coupled by an auxiliary conduit 66 to 21v sensing port 68 in the conduit means 16. The port 68 is spaced from the venturi 58 on the upstream side thereof.
To enable the patient to expire to the atmosphere, an expiration passage 72 is provided in the conduit means 16 between the main amplifier 12 and the delivery means 20. Closure of the passage 72 during the inspiratory phase of the breathing cycle is by a diaphragm'type exhalation valve 74. The lower end of the valve 74 is positioned in close proximity to the opening in the passage 72. Thus, when a slight negative pressure is drawn in the adjacent portion of the conduit means 16, the valve 74 is pulled down to close the passage 72.
Positive pressure is supplied to the valve 74 to maintain it securely closed throughout inspiration through a conduit 76 connected to the conduit means 16. Connection is at location between the main amplifier 12 and the venturi 58. It will be observed in FIGURE 1 that the cross-sectional area of the valve 74 is greater than the area of the opening in the passage 72. Thus, even though the pressure within the valve 74 is equal to, or even slightly greater than, that in the passage, i.e., the pressure acting on the underside of the valve, the latter will remain closed.
A check valve 78 biased slightly to a closed position is provided in the conduit means 16 at a location downstream of the junctions of the part 68 and the junction of the conduit 76 and upstream of the venturi 58. The valve 78 operates to block back flow from the delivery means 20 during expiration so as to insure that the valve 74 remains open during that phase. Biasing the valve 74 slightly to a closed position is desired in order to inhibit the negative pressure drawn in the conduit means '16 adjacent the delivery means 20 upon the patient exerting an inspiratory effort from acting through the conduits 66 and 76 The apparatus of the invention is readied for use by simply activating the source 18, assumingthe maximum pressure has been preset at the desired level, to deliver gas to the main amplifier 12 through the conduit means 16 and to the control amplifier 14 through the conduit 52. A main stream of gas issues from the nozzle 24 of amplifier 12 and a control stream issues from the nozzle 46 of amplifier 14. The control stream immediately seeks its preferred position and locks onto the Wall 42b of the receiving cavity 42 adjacent the expiration outlet channel 46, and flow takes place through that channel.
This output of the control amplifier 14 is delivered to the expiration control nozzle 36 of the main amplifier by the conduit 50. A positive pressure signal is caused to issue from the nozzle 36 to direct the main stream toward the exhaust channel 32. Lock-on quickly occurs and fiow of the main stream is entirely through the exhaust channel 32. As brought out above, the signal issues continuously through the expiration nozzle 36, and such signal and, in the illustrative case, the lock-on phenomenon independently serve to maintain the stream in the channel 32. The gas issuing from nozzle 36 is entrained by the main stream and the composite stream is delivered to the atmosphere.
A stable operative condition exists at this stage, such condition corresponding to the expiratory mode of operation of the apparatus 10. The flow paths through the amplifiers 12 and 14 in this stable condition are shown by the arrowed lines in FIGURE 2. It Will be appreciated that this mode of operation would continue indefinitely, absent a negative pressure in the conduit means downstream of amplifier 12.
Assuming the delivery means 20 is suitably connected to the patients respiratory system, a slight inspiratory effort on his part, as in normal breathing, serves to initiate the inspiratory phase. Such an effort produces a slight negative pressure in the conduit means 16 adjacent the delivery means 20. This first has the effect of pulling the valve 74 closed. Negative pressure then acts through the venturi 58 and conduit 64, resulting in a negative pressure signal being issued by the inspiration control nozzle 54. This negative pressure signal, in turn, acts on the control stream with sufiicient influence to break the lock-on phenomenon and move the stream toward the inspiration outlet channel 44. In this manner, the control stream is directed or switched to the channel 44 in opposition to the biasing force inherent in the structure of the amplifier 14 and normally causing that stream to seek its preferred, stable condition. The valve 78, being slightly biased to a closed position, insures that negative pressure is inhibited from simultaneously acting through the conduits 66 and "76 in such a manner as to adversely affect the switching operation.
Switching of the control amplifier in the manner described above has the effect of switching the main amplifier 12. Referring to FIGURE 2, the pressure signal issued by the nozzle 36 terminates and a similar signal, supplied by amplifier 14 through the conduit 48, issues from inspiration control nozzle 34. The main stream is thereby directed toward the patient channel 30, whereupon lock-on takes place, and the stream is maintained in that channel by both the continuously-issuing signal and the lock-on phenomenon. The composite stream, including gas from the control amplifier 14 entrained by the main stream, then flows through the downstream section of the conduit means 16 to the patient. Once main stream flow occurs through the conduit means 16 to the patient, a positive pressure is applied to the valve 74 to forcefully maintain it seated, and this condition exists throughout the remainder of inspiration.
Characteristic of the inspiratory phase of a normal breathing cycle is a high flow requirement near the start of the phase. Accordingly, flow through the conduit means 16 and the venturi 58 installed therein is initially at a relatively high rate, while pressure is relatively low. In this connection, it is to be observed that the venturi 58 serves advantageously as a sensing element without appreciably restricting fiow. In other words, system pressure in the conduit means 16 on opposite sides of the venturi 58 is substantially the same.
At relatively high flow rates, as near the start of inspiration, a substantial pressure drop is produced at the throat 62 of the venturi 58. It may even serve at this stage to produce a negative pressure (with respect to ambient pressure) in the conduit 64 leading to the nozzle 54. In any event, a relatively low pressure signal issues from the nozzle 54 by virtue of the action of the venturi 58. On the other hand, higher pressure is sensed by the port 68 in the conduit means 16 downstream of the venturi 58. The latter pressure is, in turn, transmitted through the conduit 66 and issues as a positive pressure signal from the nozzle 56. It will, therefore, be appreciated that at this stage of inspiration, counteracting pressure signals of different amplitudes act on the control stream, which is then flowing through the inspiration outlet channel 44. Since the amplitude of the signal issuing from the nozzle 54 is substantially greater than that issuing from the nozzle 56, the control stream is maintained in the channel 44 in opposition to its memory or tendency to move back to its preferred position in channel 46.
As inspiration progresses, the How rate through the main conduit means 16 decreases, while system pressure correspondingly increases. Some spill over of the main stream from the patient channel 30 to the exhaust channel 32 may even occur near the end of inspiration when the back pressure is substantial. With such decreasing flow through the main conduit means 16, the pressure drop produced at the throat 62 of the venturi 58 likewise decreases. Therefore, the difference in amplitudes of the pressure signals issuing from the nozzles 54 and 56 diminishes. It will be noted that the venturi 58 with the passage 60 is at its throat 62 and the port 68 cooperate during the latter part of inspiration to sense flow through the conduit means independently of absolute pressures. It is the difference in pressures transmitted through the conduits 64 and 66 and issuing from the nozzles 54 and 56 that maintains the apparatus in its inspiratory mode of operation, and such difference varies in accordance with fiow through the conduit means. Eventually, when the flow through the main conduit means 16 drops to the terminal flow, the difference in amplitudes of these pres sure signals is insufficient to overcome the tendency of the control stream to return to its preferred position, and the stream switches back to the expiration outlet channel 46.
By appropriately sizing and shaping the parts, particularly the control amplifier 12 and the venturi 58, the terminal flow can be established at the desired level. In most operational situations, it is desired that such flow be less than liters per minute and this can readily be accomplished with the apparatus of the invention. Moreover, it can be accomplished without impairing the capability of the apparatus to meet the patients peak flow capacity.
Responsive to the control stream in the control amplifier 12 switching back to its preferred, stable position in the expiration outlet channel 46, the main amplifier 12 Switches to its expiratory mode of operation in the manner previously described. As set forth above, flow through this amplifier takes place as shown by the arrowed lines in FIGURE 2. Main stream flow is through the exhaust channel 32 to the atmosphere, and this serves immediately to relieve pressure in the downstream section of the conduitmeans 16. The exhalation valve 74 opens passage 72 and the patient is free to expire to the atmosphere through the pasage 72. It is to be noted that expired gas is prevented by the check valve 78 from flowing back through the conduit means 16 to the interior of the exhalation valve 74.
The apparatus then remains in its expiratory mode, as in FIGURES 1 and 2, until expiration is completed. This constitutes one complete breathing cycle. It will be understood that the next, as well as all subsequent cycles, commence in the same manner as described above.
A slightly modified version of the apparatus of the invention, designated by the reference numeral 100, is illustrated in FIGURES 3 and 4. Many of the elements of the apparatus 100 are identical to the elements of apparatus 10. To simplify the description, like elements of the two embodiments have been identified with like numerals and are not again described. In the case of the latter apparatus 100, the numerals carry a prime subscript. It is observed that in the case of the main amplifier 12, the patient and exhaust channels 30 and 32 have been reversed from top to bottom as compared to their orientation in amplifier 12 in FIGURE 2. However, this amplifier is symmetrical about a horizontal center line and, therefore, this presents no problem.
The principal difference between the present embodiment over the former is in the means for sensing negative pressure in the conduit means 16 to initiate inspiration and, thereafter, for sensing flow through the conduit means to continue inspiration until the flow drops to the terminal flow. In this instance a restrictor 102 is provided in the conduit means 16' intermediate the main amplifier 12' and the delivery means 20'. Ports 104 and 106 are provided in the conduit means 16 on the upstream and downstream sides, respectively, of the restrictor 102, and connected by conduits 108 and 110 to the nozzles 54' and 56 of the control amplifier 14.
Inspiration is initiated in the case of the apparatus 100 by negative pressure acting through the conduit 110 and issuing as a negative presure signal from the nozzle 54. T o prevent a like signal from issuing from the nozzle 56 and counterbalancing the desired triggering signal, a vent passage 112 is provided in the conduit 108. The passage 112 is adapted to be closed from the exterior by a diaphragm-type valve 114, similar to the exhalation valve 74 of the apparatus 10, disposed in close proximity to the opening of the pasage 112. Pressure is supplied internally to the valve 114 for actuating it through a c0nduit 116 connected to the main conduit means 16' between the port 104 and the restrictor 102.
As in the case of the exhalation valve 74 of the prior embodiment, the effective crosssectional area of the valve 114 is greater than the area of the opening to the associated passage 112. Thus, the valve 116 will be open or closed, depending upon whether there is a positive or negative pressure existing in the main conduit means 16' adjacent the junction with the conduit 116.
This is true notwithstanding the fact that an equal pres sure exists in the auxiliary conduit 108 adjacent the vent passage 112. Thus, the valve 114 will be drawn off its seat to open the passage 112 when the patient exerts a negative pressure to initiate inspiration and will be seated to close the passage during periods in which gas is being delivered to the patient through the main conduit means 16'. To insure that the negative pressure acts in the desired manner through the conduit 110 when the valve 114 is open, a restrictor 118 is provided in the conduit 108.
As is well known, the pressure drop across a restrictor in a gas flow path will vary in accordance with the flow rate. In the case of the present apparatus, it is the pressure differential produced by the restrictor 102 and transmitted to the amplifier 14 that overcomes the tendency of the control stream to move to its stable preferred position, maintaining the apparatus in its inspiratory mode of operation. When flow through the conduit means 16 exceeds the predetermined terminal flow, the pressure differential is sufiicient to maintain the control stream in the inspiration outlet channel 44'. On the other hand, when flow drops to the terminal flow, such differential is insufficient.
Briefly reviewing the operation of the apparatus 100, upon the source 18 being activated, the apparatus assumes its expiratory mode of operation. The flow paths through amplifiers 12 and 14' are as shown in FIGURE 4, with the gas from the source 18 being vented to the atmosphere through the exhaust channel 32' of the main amplifier 12'. As slight inspiratory effort on the part of the patient produces a negative presure in the conduit means 16' adjacent the delivery means 20'. Such pressure acts through the passage 72 to draw the exhalation valve 74 closed, and through the conduit 116 to draw the valve 114 off its seat. Accordingly, an ambient pressure will exist in the conduit 108 adjacent the nozzle 56'. On the other hand, a negative pressure will act through the conduit 110 and issue as a negative pressure signal from the nozzle 54. This signal then serves to break the lockon phenomenon and draw the control stream from the expiration outlet channel 46' toward the inspiration outlet channel 44.
Switching of the control amplifier 14', in turn, switches the main amplifier 12, so that main stream flow is supplied through the patient channel 30' and conduit means 16' to the patient. Positive pressure in the conduit means acts through the conduits 76' and 116 to maintain the valves 74 and 114 closed. Moreover, as flow takes place, pressures in the conduit means 16 at the locations of the ports 104 and 106 on opposite sides of the restrictor 102 are sensed and supplied through the conduits 1'08 and 110 as positive pressure signals counterbalancing one another to the nozzles 56' and 54. Provided the flow rate through the conduit means 16' exceeds the terminal flow, the amplitude of the signal issuing from nozzle 56' is sufficiently higher than that issuing from nozzle 54 to maintain the control stream in the inspiration outlet channel 44'.
As the patient becomes fully ventilated, the pressure differential across the restrictor 102 sensed at the parts 104 and 106 diminishes, and when the terminal flow is reached, such differential is insufiicient to maintain the stream in the channel 44'. Accordingly, it switches back to the expiration outlet channel 46' to complete a breathin g cycle.
In the case of apparatus the desired terminal flow can be established by appropriately sizing the restrictor 102, as well as by appropriately sizing and shaping the control amplifier 14. In this connection, it is noted that the restriction afforded by the restrictor 102 should not be such as to unduly restrict the peak flow capacity of the apparatus. In general, it is desired that at an average control pressure, the apparatus be capable of delivering up to 100 liters per minute of gas in order to meet the patients peak flow requirement. By appropriate sizing of the various parts, the apparatus can be made to satisfy this requirement, yet still have a relatively low terminal flow on the order of less than liters per minute.
While certain embodiments of the invention have been illustrated and described in considerable detail, it will be understood that this is only a way of illustration, and that numerous changes in the details of the construction and arrangement of the various parts may be made without departing from the spirit and scope of the invention.
I claim:
1. In respiration apparatus including a source of pressurized gas and delivery means, the combination of:
main conduit means adapted to connect the source and the delivery means; a main fluid control means in said main conduit means having an inspiration state in which flow takes place from said source to said delivery means and an expiration state in which said flow is terminated, said control means being actuated by means applying pressure signals to move said control means between its inspiration and expiration states;
flow responsive means in said main conduit means intermediate said control means and said delivery means and having a pair of sensing ports at which pressures of different magnitudes are sensed during flow through said main conduit means; and
a control fluid amplifier coupled to said control means and having a power nozzle connected to said source, inspiration and expiration outlet channels for receiving, alternately, a control stream of gas issuing from said power nozzle and connected to said means for applying pressure signals whereby said control means is actuated to its inspiration state when said control stream is flowing through said inspiration outlet channel and being actuated to its expiration state when said control stream is flowing through said expiration outlet channel, and first and second control nozzles coupled to said first and second sensing ports, respectively and arranged to issue pressure signals to direct said control stream between said inspiration and expiration outlet channels.
2. In respiration apparatus including a source of pressurized gas and delivery means, the combination of:
main conduit means adapted to connect the source and the delivery means;
a main fluid amplifier in said conduit means having a main nozzle connected to said conduit means on the upstream side of said amplifier, an exhaust channel vented to the atmosphere, a patient channel connected to said conduit means on the downstream side of said amplifier,
said exhaust and patient channels being arranged to receive, alternately, a main stream of gas issuing from said main nozzle, and inspiration and expiration control nozzles arranged to issue pressure signals to direct said main stream toward said exhaust and patient channels, respectively; flow responsive means in said main conduit means intermediate said main fluid amplifier and said delivery means having a pair of sensing ports at which pressures of different magnitudes are sensed during flow through said main conduit means; and a control fluid amplifier having a power nozzle, an inspiration outlet channel connected to said inspiration control nozzle, an expiration outlet channel connected to said expiration control nozzle,
said inspiration and expiration outlet channels being arranged to receive, alternately, a control stream of gas issuing from said power nozzle,
fluid amplifier is of the monostable type with a stable, prefer-red position in which said control stream is received by said expiration outlet channel.
4. The subject matter of claim 3, wherein said main fluid amplifier is of the bistable type.
surized gas and delivery means, the combination of:
main conduit means adapted to connect'the source and the delivery means; a main fluid amplifier in said conduit means having a main nozzle connected to said conduit means on the upstream side of said amplifier, an exhaust channel vented to the atmosphere, a patient channel connected to said conduit means on the downstream side of said amplifier,
said exhaust and patient channels being arranged to receive a main stream of gas issuing from said main nozzle, and first control nozzle means for issuing a positive pressure signal for directing said main stream from said exhaust channel toward said patient channel; flow-responsive means in said main conduit means intermediate said main fluid amplifier and said delivery means having first and second sensing ports at which pressured of different magnitudes are sensed during flow through said main conduit means; and a control fluid amplifier having a power nozzle connected to said source, inspiration and expiration outlet channels for receiving, alternately, a control stream of gas issuing from said power nozzle,
said outlet channels being connected to said first control nozzle means and arranged so that when said control stream is directed from said expiration outlet channel toward said inspiration outlet channel, a positive pressure signal is issued by said first control nozzle means to direct said main stream toward said patient channel, first and second control nozzles coupled to said first and second sensing ports, respectively, and arranged to issue pressure signals to direct said control stream bewteen said inspiration and expiration outlet channels. 6. In respiration apparatus including a source of pressurized gas and delivery means, the combination of:
main conduit means adapted to connect the source and the delivery means; a main fluid amplifier in said conduit means having a main nozzle connected to said conduit means on the upstream side of said amplifier, an exhaust channel vented to the atmosphere, a patient channel connected to said conduit means on the downstream side of said amplifier,
said exhaust and patient channels being arranged to receive a main stream of gas issuing from said main nozzle, and first control nozzle means for issuing a pressure signal for directing said main stream from said exhaust channel to said patient channel; flow-responsive means in said main conduit means intermediate said main fluid amplifier and said delivery means having a pair of sensing ports at which pressures of different magnitudes are sensed during fiow through said main conduit means; and a control fluid amplifier having a power nozzle connected to said source, inspiration and expiration outlet channels for receiving a control stream of gas issuing from said power nozzle,
said outlet channels being connected to said first control nozzle means and arranged so that when said control stream is directed from said expiration outlet channel to said inspiration outlet channel, a positive pressure signal is issued by said first control nozzle means to direct said main stream toward said patient channel, and so that when said control stream is directed from said inspiration outlet channel to said expiration outlet channel, a positive pressure signal is issued by said first control means to direct said main stream toward said exhaust channel, and second control nozzle means having a pair of nozzles connected, one each, to said ports of said fiow-responsive means, to
said second control nozzle means being responsive to a negative pressure in said conduit means adjacent the delivery means for issuing a pressure signal for directing said control stream from said expiration outlet channel to said inspiration outlet channel, and responsive to flow through said main conduit means at a rate greater than a predetermined terminal flow for issuing a pressure signal for maintaining said control stream in said inspiration outlct channel. 7. In respiration apparatus including a source of pressurized gas and delivery means, the combination of:
main conduit means adapted to connect the source and the delivery means;
a main fluid amplifier in said conduit means having a main nozzle connected to said main conduit means on the upstream side of said amplifier, an exhaust channel vented to the atmosphere, a patient channel connected to said main conduit means on the downstream side of said amplifier,
said exhaust and patient channels being arranged to receive, alternately, a main stream of gas issuing from said main nozzle, and inspiration and expiration control nozzles arranged to issue pressure signals to direct said main stream to said exhaust and patient channels, respectively; a control fluid amplifier having a power nozzle connected to said source, an inspiration outlet channel connected to said inspiration control nozzle, an expiration outlet channel connected to said expiration control nozzle,
said inspiration and expiration outlet channels being arranged to receive, alternately, a control stream of gas issuing from said power nozzle with said expiration outlet channel being the preferred position of said control stream,
first and second control nozzles arranged to issue pressure signals to direct said control stream between said inspiration and expiration outlet channels;
a venturi having a throat in said main conduit means intermediate said main fluid amplifier and the delivery means, there being a passageway in said venturi with an opening at said throat;
first auxiliary conduit means connecting said first controlnozzle and said main conduit means at a location spaced from said venturi; and
second auxiliary conduit means connecting said second control nozzle and said passageway in said venturi. 8. The subject matter of claim 7, wherein said first auxiliary conduit means is connected to said main conduit means at a location upstream of said venturi, and including a main check valve in said main conduit means at a location between the connection of said first auxiliary conduit means to said main conduit means and said venturi, said main check valve being slightly biased to a closed position and arranged to block flow through said main conduit means from said delivery means toward said main amplifier, but to permit flow in the opposite direction.
9. In respiration apparatus including a source of pressurized gas and delivery means, the combination of:
main conduit means adapted to connect the source and the delivery means; a main fluid amplifier in said conduit means having a main nozzle connected to said conduit means on the upstream side of said amplifier, an exhaust channel vented to the atmosphere, a patient channel connected to said conduit means on the downstream side of said amplifier,
said exhaust and patient channels being arranged to receive, alternately, a main stream of gas issuing from said main nozzle, and inspiration and expiration control nozzles arranged to issue pressure signals to direct said main stream to said exhaust and patient channels, respectively; a control fluid amplifier having a power nozzle connected to said source, an inspiration outlet channel connected to said inspiration control nozzle, an expiration outlet channel connected to said expiration control nozzle,
said inspiration and expiration outlet channels being arranged to receive, alternately, a control stream of gas issuing from said power nozzle with said expiration outlet channel being the preferred position of said control stream, first and second control nozzles arranged to issue pressure signals to direct said control stream between said inspiration and expiration outlet channels; means forming a restriction in said conduit means intermediate said main fluid amplifier and said delivery means; first auxiliary conduit means connecting said first control nozzle and said main conduit means at a location downstream of said restriction; second auxiliary conduit means connecting said second control nozzle and said main conduit means at a location upstream of said restriction; means forming a vent passage in said second conduit means; and valve means for closing said vent passage responsive to a positive pressure in said main conduit means.
References Cited RICHARD A. GAUDET, Primary Examiner.
K. L. HOWELL, Assistant Examiner.

Claims (1)

1. IN RESPIRATION APPARATS INCLUDING A SOURCE OF PRESSURIZED GAS AND DELIVERY MEANS, THE COMBINATION OF: MAIN CONDUIT MEANS ADAPTED TO CONNECT THE SOURCE AND THE DELIVERY MEANS; A MAIN FLUID CONTROL MEANS IN SAID MAIN CONDUIT MEANS HAVING AN INSPIRATION STATE IN WHICH FLOW TAKES PLACE FROM SAID SOURCE TO SAID DELIVERY MEANS AND AN EXPIRATION STATE IN WHICH SAID FLOW IS TERMINATED, SAID CONTROL MEANS BEING ACTUATED BY MEANS APPLYING PRESSURE SIGNALS TO MOVE SAID CONTROL MEANS BETWEEN ITS INSPIRATION AND EXPIRATION STATES; FLOW RESPONSIVE MEANS IN SAID MAIN CONDUIT MEANS INTERMEDIATE SAID CONTROL MEANS AND SAID DELIVERY MEANS AND HAVING A PAIR OF SENSING PORTS AT WHICH PRESSURES OF DIFFERENT MAGNITUDE ARE SENSED DURING FLOW THROUGH SAID MAIN CONDUIT MEANS; AND A CONTROL FLUID AMPLIFIER COUPLED TO SAID CONTROL MEANS AND HAVING A POWER NOZZLE CONNECTED TO SAID SOURCE, INSPIRATION AND EXPIRATION OUTLET CHANNELS FOR RECEIVING, ALTERNATELY, A CONTROL STREAM OF GAS ISSUING FROM SAID POWER NOZZLE AND CONNECTED TO SAID MEANS FOR
US51158865 1965-12-02 1965-12-02 Respiration apparatus with fluid amplifier Expired - Lifetime US3368555A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US51158865 US3368555A (en) 1965-12-02 1965-12-02 Respiration apparatus with fluid amplifier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51158865 US3368555A (en) 1965-12-02 1965-12-02 Respiration apparatus with fluid amplifier

Publications (1)

Publication Number Publication Date
US3368555A true US3368555A (en) 1968-02-13

Family

ID=24035554

Family Applications (1)

Application Number Title Priority Date Filing Date
US51158865 Expired - Lifetime US3368555A (en) 1965-12-02 1965-12-02 Respiration apparatus with fluid amplifier

Country Status (1)

Country Link
US (1) US3368555A (en)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3435822A (en) * 1965-06-29 1969-04-01 United Aircraft Corp Breathing apparatus with fluid diode valve
US3472225A (en) * 1963-11-18 1969-10-14 Cavitron Corp Fluid inverter
US3494357A (en) * 1968-02-05 1970-02-10 Sperry Rand Corp Fluidic respirator
US3610236A (en) * 1966-11-22 1971-10-05 Globe Safety Products Inc Resuscitator device
US3683951A (en) * 1971-05-24 1972-08-15 Georges Beaumont Periodic gas generator
US3739775A (en) * 1970-05-18 1973-06-19 Medicor Muevek Pneumatic pressure type respirator
US3815593A (en) * 1970-01-16 1974-06-11 Le Materiel Medical Scient Static respirator for artificial respiration
US4240419A (en) * 1977-09-26 1980-12-23 Normalair-Garrett (Holdings) Limited Breathable gas delivery regulators
US4278110A (en) * 1979-11-13 1981-07-14 Price Ernest H Demand responsive flow controller
US4289126A (en) * 1979-05-02 1981-09-15 Wisconsin Alumni Research Foundation Pressure regulator for breathing apparatus
US4316458A (en) * 1978-05-09 1982-02-23 National Research Development Corporation Patient ventilators
US4381002A (en) * 1980-12-18 1983-04-26 The United States Of America As Represented By The Secretary Of The Army Fluidic-controlled oxygen intermittent demand flow device
FR2521432A1 (en) * 1982-02-18 1983-08-19 App Medical Precision Regulator for respirator gas supply - has vacuum chamber contg. membrane responsive to breathing action to control flow from buffer reservoir and main supply
US4456016A (en) * 1982-07-01 1984-06-26 Trutek Research, Inc. Inhalation valve
WO1987002590A1 (en) * 1985-11-05 1987-05-07 Shattuck, Leonard, L. Positive-flow, demand responsive, respiratory regulator
US5423313A (en) * 1981-03-10 1995-06-13 Siemens-Elema Ab Respirator intended for connection to human or animal airways
WO2003026730A1 (en) * 2001-09-25 2003-04-03 Fisher & Paykel Healthcare Limited Flow switch
US20040031485A1 (en) * 2002-08-19 2004-02-19 Andre Rustad Small volume nebulizer
US20040139786A1 (en) * 2003-01-17 2004-07-22 Dirk Henf Testing device for a respiration product
US20070017519A1 (en) * 2005-07-23 2007-01-25 Dragerwerk Aktiengesellschaft Process and device for setting a gas flow distribution of a breathing gas mixture in a branching breathing gas line
WO2015132682A1 (en) * 2014-03-04 2015-09-11 Koninklijke Philips N.V. Blending gaz enriched pressure support system and method
US11844906B1 (en) * 2021-04-29 2023-12-19 Selvaanish Selvam Oxygen-air blender for neonates

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3223101A (en) * 1963-05-28 1965-12-14 Romald E Bowles Binary stage
US3244189A (en) * 1963-10-04 1966-04-05 Feedback Systems Inc Fluid valve device
US3280832A (en) * 1963-11-18 1966-10-25 Retec Inc Cycling valve
US3292623A (en) * 1964-02-24 1966-12-20 Raymond W Warren Respirator

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3223101A (en) * 1963-05-28 1965-12-14 Romald E Bowles Binary stage
US3244189A (en) * 1963-10-04 1966-04-05 Feedback Systems Inc Fluid valve device
US3280832A (en) * 1963-11-18 1966-10-25 Retec Inc Cycling valve
US3292623A (en) * 1964-02-24 1966-12-20 Raymond W Warren Respirator

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472225A (en) * 1963-11-18 1969-10-14 Cavitron Corp Fluid inverter
US3435822A (en) * 1965-06-29 1969-04-01 United Aircraft Corp Breathing apparatus with fluid diode valve
US3610236A (en) * 1966-11-22 1971-10-05 Globe Safety Products Inc Resuscitator device
US3494357A (en) * 1968-02-05 1970-02-10 Sperry Rand Corp Fluidic respirator
US3815593A (en) * 1970-01-16 1974-06-11 Le Materiel Medical Scient Static respirator for artificial respiration
US3739775A (en) * 1970-05-18 1973-06-19 Medicor Muevek Pneumatic pressure type respirator
US3683951A (en) * 1971-05-24 1972-08-15 Georges Beaumont Periodic gas generator
US4240419A (en) * 1977-09-26 1980-12-23 Normalair-Garrett (Holdings) Limited Breathable gas delivery regulators
US4316458A (en) * 1978-05-09 1982-02-23 National Research Development Corporation Patient ventilators
US4289126A (en) * 1979-05-02 1981-09-15 Wisconsin Alumni Research Foundation Pressure regulator for breathing apparatus
US4278110A (en) * 1979-11-13 1981-07-14 Price Ernest H Demand responsive flow controller
US4381002A (en) * 1980-12-18 1983-04-26 The United States Of America As Represented By The Secretary Of The Army Fluidic-controlled oxygen intermittent demand flow device
US5423313A (en) * 1981-03-10 1995-06-13 Siemens-Elema Ab Respirator intended for connection to human or animal airways
FR2521432A1 (en) * 1982-02-18 1983-08-19 App Medical Precision Regulator for respirator gas supply - has vacuum chamber contg. membrane responsive to breathing action to control flow from buffer reservoir and main supply
US4456016A (en) * 1982-07-01 1984-06-26 Trutek Research, Inc. Inhalation valve
WO1987002590A1 (en) * 1985-11-05 1987-05-07 Shattuck, Leonard, L. Positive-flow, demand responsive, respiratory regulator
WO2003026730A1 (en) * 2001-09-25 2003-04-03 Fisher & Paykel Healthcare Limited Flow switch
US20040031485A1 (en) * 2002-08-19 2004-02-19 Andre Rustad Small volume nebulizer
US7267120B2 (en) 2002-08-19 2007-09-11 Allegiance Corporation Small volume nebulizer
US20040139786A1 (en) * 2003-01-17 2004-07-22 Dirk Henf Testing device for a respiration product
US20070017519A1 (en) * 2005-07-23 2007-01-25 Dragerwerk Aktiengesellschaft Process and device for setting a gas flow distribution of a breathing gas mixture in a branching breathing gas line
WO2015132682A1 (en) * 2014-03-04 2015-09-11 Koninklijke Philips N.V. Blending gaz enriched pressure support system and method
US11278698B2 (en) 2014-03-04 2022-03-22 Koninklijke Philips N.V. Blending gas enriched pressure support system and method
US11844906B1 (en) * 2021-04-29 2023-12-19 Selvaanish Selvam Oxygen-air blender for neonates

Similar Documents

Publication Publication Date Title
US3368555A (en) Respiration apparatus with fluid amplifier
US5000173A (en) Respiratory aid device
US4278110A (en) Demand responsive flow controller
US5036847A (en) Breathing aid
US4865027A (en) Non-rebreathing collapsible chamber continuous aerosol delivery system with infusion port
US4245633A (en) PEEP providing circuit for anesthesia systems
US2453475A (en) Resuscitation apparatus
US3385295A (en) Apparatus for use in administering intermittent positive pressure breathing therapy
US3817246A (en) Flow responsive respiration apparatus
US3865106A (en) Positive pressure breathing circuit
CA2223328C (en) Pneumatically-operated gas demand apparatus
US3362404A (en) Respiration apparatus for administering intermittent positive pressure breathing therapy
JPH0265872A (en) Air force type control valve
US3586021A (en) Fluidic breathing assistor
US6237594B1 (en) Pneumatically-operated gas demand apparatus
US20020046753A1 (en) Breathing aid device
JPS6319189B2 (en)
US3653379A (en) Adjustable pressure ippb ventilator
CA1184471A (en) Ventilation apparatus for artificial respiration
US3251359A (en) Automatic intermittent positive pressure ventilators
US3537449A (en) Respirator using pure fluid amplifier
US3292623A (en) Respirator
US20060107947A1 (en) Device for influencing gas flows
US4227519A (en) Respirator for emergency air supply to a patient
US1693730A (en) Breathing apparatus particularly for administering anesthetics